Moon (Guangzhou) Biotechnology Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   AKM Lab-01 · Akkermansia Muciniphila AKM Lab-01 in…AKM Lab-01 · Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia

   Enrollment closed, study ongoing

   Also in this update: Primary completion pushed from Jul 30, 2026 to Oct 30, 2026

   Moon (Guangzhou) Biotechnology Co., Ltd.·Not applicable· NCT06974266· Registry history of NCT06974266 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

2. Minor

   Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity

   Primary completion pushed from Jan 31, 2027 to Mar 31, 2027

   Also in this update: Completion pushed from May 31, 2027 to Jun 30, 2027

   Moon (Guangzhou) Biotechnology Co., Ltd.·Not applicable· NCT07331974· Registry history of NCT07331974 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.